In patients with baseline hs-CRP > 5 mg/L, a monoclonal antibody drug directed at TNF-α (infliximab) can significantly reduce depressive symptoms, including depressed mood, anxiety, and suicidal ideation (40). The gene discussed is CRP; the disease is Anxiety.